Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells
Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study...
Gespeichert in:
Veröffentlicht in: | Life sciences (1973) 2010-08, Vol.87 (9), p.294-301 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 301 |
---|---|
container_issue | 9 |
container_start_page | 294 |
container_title | Life sciences (1973) |
container_volume | 87 |
creator | Yamazaki, Takashi Ohmi, Asako Kurumaya, Haruka Kato, Kenji Abe, Takanori Yamamoto, Hiroyuki Nakanishi, Noriko Okuyama, Ryuichi Umemura, Mariko Kaise, Toshikazu Watanabe, Ryuya Okawa, Yoshiko Takahashi, Shigeru Takahashi, Yuji |
description | Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein (
CHOP) gene expression.
We used a transient transfection system to express ATF5 and analyzed the regulation of
CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
We showed that ATF5 activates the
CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the
CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
These results suggested that the
CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced
CHOP gene expression level via the AARE1 site in HepG2 cells. |
doi_str_mv | 10.1016/j.lfs.2010.07.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_817605073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320510002936</els_id><sourcerecordid>817605073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</originalsourceid><addsrcrecordid>eNqFkc1q3DAUhUVpaaZpH6Cbol1XnlxJluyhq2FIMoVASkjXQpavMxpsy5XkQN6hD13NT7tMN7qI-52DdA4hnxksGTB1tV_2XVxyyHeolgDqDVmwuloVoAR7SxYAvCwEB3lBPsS4BwApK_GeXHBQsszMgvx-wKe5N8n5kfqOph3S3TyYkW629z_oE45Ip-AHnzDQ5uW4jylgjDQfkx8j0hTMGG1w09GkMzb5QNePN5I-O3NUrNcP14xGl5C68ey_w8kkPxi6xemWU4t9Hz-Sd53pI346z0vy8-b6cbMt7u5vv2_Wd4UtJaSiarlSUmDd8FWprGKildKg4IyrrjG1BW45X0nBjaiYlGXJRVOLjrG6UzkscUm-nnzz137NGJMeXDy8wIzo56hrVimQUIn_klW5OoTK60yyE2mDjzFgp6fgBhNeNAN9aEvvdW5LH9rSUOncVtZ8ObvPzYDtP8XfejLw7QRgTuPZYdDROhwtti6gTbr17hX7P684o1Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749005528</pqid></control><display><type>article</type><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</creator><creatorcontrib>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</creatorcontrib><description>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein (
CHOP) gene expression.
We used a transient transfection system to express ATF5 and analyzed the regulation of
CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
We showed that ATF5 activates the
CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the
CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
These results suggested that the
CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced
CHOP gene expression level via the AARE1 site in HepG2 cells.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2010.07.006</identifier><identifier>PMID: 20654631</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Activating Transcription Factors - antagonists & inhibitors ; Activating Transcription Factors - genetics ; Activating Transcription Factors - physiology ; Activator protein 1 ; Amino Acids - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Arsenite ; Arsenites - pharmacology ; ATF5 ; Binding Sites ; Blotting, Western ; Cell Survival - drug effects ; CHOP ; Cloning, Molecular ; DDIT3 ; Dose-Response Relationship, Drug ; GADD153 ; Gene Deletion ; Gene Expression Regulation, Neoplastic - drug effects ; HeLa Cells ; Hep G2 Cells ; Humans ; Luciferases - genetics ; Plasmids ; Point Mutation ; Promoter Regions, Genetic ; Response Elements - genetics ; RNA, Small Interfering - pharmacology ; Sodium Compounds - pharmacology ; Transcription Factor AP-1 - genetics ; Transcription Factor CHOP - genetics ; Transfection ; Up-Regulation</subject><ispartof>Life sciences (1973), 2010-08, Vol.87 (9), p.294-301</ispartof><rights>2010 Elsevier Inc.</rights><rights>Copyright (c) 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</citedby><cites>FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2010.07.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20654631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamazaki, Takashi</creatorcontrib><creatorcontrib>Ohmi, Asako</creatorcontrib><creatorcontrib>Kurumaya, Haruka</creatorcontrib><creatorcontrib>Kato, Kenji</creatorcontrib><creatorcontrib>Abe, Takanori</creatorcontrib><creatorcontrib>Yamamoto, Hiroyuki</creatorcontrib><creatorcontrib>Nakanishi, Noriko</creatorcontrib><creatorcontrib>Okuyama, Ryuichi</creatorcontrib><creatorcontrib>Umemura, Mariko</creatorcontrib><creatorcontrib>Kaise, Toshikazu</creatorcontrib><creatorcontrib>Watanabe, Ryuya</creatorcontrib><creatorcontrib>Okawa, Yoshiko</creatorcontrib><creatorcontrib>Takahashi, Shigeru</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein (
CHOP) gene expression.
We used a transient transfection system to express ATF5 and analyzed the regulation of
CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
We showed that ATF5 activates the
CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the
CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
These results suggested that the
CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced
CHOP gene expression level via the AARE1 site in HepG2 cells.</description><subject>Activating Transcription Factors - antagonists & inhibitors</subject><subject>Activating Transcription Factors - genetics</subject><subject>Activating Transcription Factors - physiology</subject><subject>Activator protein 1</subject><subject>Amino Acids - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Arsenite</subject><subject>Arsenites - pharmacology</subject><subject>ATF5</subject><subject>Binding Sites</subject><subject>Blotting, Western</subject><subject>Cell Survival - drug effects</subject><subject>CHOP</subject><subject>Cloning, Molecular</subject><subject>DDIT3</subject><subject>Dose-Response Relationship, Drug</subject><subject>GADD153</subject><subject>Gene Deletion</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>HeLa Cells</subject><subject>Hep G2 Cells</subject><subject>Humans</subject><subject>Luciferases - genetics</subject><subject>Plasmids</subject><subject>Point Mutation</subject><subject>Promoter Regions, Genetic</subject><subject>Response Elements - genetics</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Sodium Compounds - pharmacology</subject><subject>Transcription Factor AP-1 - genetics</subject><subject>Transcription Factor CHOP - genetics</subject><subject>Transfection</subject><subject>Up-Regulation</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1q3DAUhUVpaaZpH6Cbol1XnlxJluyhq2FIMoVASkjXQpavMxpsy5XkQN6hD13NT7tMN7qI-52DdA4hnxksGTB1tV_2XVxyyHeolgDqDVmwuloVoAR7SxYAvCwEB3lBPsS4BwApK_GeXHBQsszMgvx-wKe5N8n5kfqOph3S3TyYkW629z_oE45Ip-AHnzDQ5uW4jylgjDQfkx8j0hTMGG1w09GkMzb5QNePN5I-O3NUrNcP14xGl5C68ey_w8kkPxi6xemWU4t9Hz-Sd53pI346z0vy8-b6cbMt7u5vv2_Wd4UtJaSiarlSUmDd8FWprGKildKg4IyrrjG1BW45X0nBjaiYlGXJRVOLjrG6UzkscUm-nnzz137NGJMeXDy8wIzo56hrVimQUIn_klW5OoTK60yyE2mDjzFgp6fgBhNeNAN9aEvvdW5LH9rSUOncVtZ8ObvPzYDtP8XfejLw7QRgTuPZYdDROhwtti6gTbr17hX7P684o1Y</recordid><startdate>20100828</startdate><enddate>20100828</enddate><creator>Yamazaki, Takashi</creator><creator>Ohmi, Asako</creator><creator>Kurumaya, Haruka</creator><creator>Kato, Kenji</creator><creator>Abe, Takanori</creator><creator>Yamamoto, Hiroyuki</creator><creator>Nakanishi, Noriko</creator><creator>Okuyama, Ryuichi</creator><creator>Umemura, Mariko</creator><creator>Kaise, Toshikazu</creator><creator>Watanabe, Ryuya</creator><creator>Okawa, Yoshiko</creator><creator>Takahashi, Shigeru</creator><creator>Takahashi, Yuji</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20100828</creationdate><title>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</title><author>Yamazaki, Takashi ; Ohmi, Asako ; Kurumaya, Haruka ; Kato, Kenji ; Abe, Takanori ; Yamamoto, Hiroyuki ; Nakanishi, Noriko ; Okuyama, Ryuichi ; Umemura, Mariko ; Kaise, Toshikazu ; Watanabe, Ryuya ; Okawa, Yoshiko ; Takahashi, Shigeru ; Takahashi, Yuji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-7d26653e8b2946c613d55ae32126fba8c02c229532a371554423b83f118f60103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Activating Transcription Factors - antagonists & inhibitors</topic><topic>Activating Transcription Factors - genetics</topic><topic>Activating Transcription Factors - physiology</topic><topic>Activator protein 1</topic><topic>Amino Acids - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Arsenite</topic><topic>Arsenites - pharmacology</topic><topic>ATF5</topic><topic>Binding Sites</topic><topic>Blotting, Western</topic><topic>Cell Survival - drug effects</topic><topic>CHOP</topic><topic>Cloning, Molecular</topic><topic>DDIT3</topic><topic>Dose-Response Relationship, Drug</topic><topic>GADD153</topic><topic>Gene Deletion</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>HeLa Cells</topic><topic>Hep G2 Cells</topic><topic>Humans</topic><topic>Luciferases - genetics</topic><topic>Plasmids</topic><topic>Point Mutation</topic><topic>Promoter Regions, Genetic</topic><topic>Response Elements - genetics</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Sodium Compounds - pharmacology</topic><topic>Transcription Factor AP-1 - genetics</topic><topic>Transcription Factor CHOP - genetics</topic><topic>Transfection</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamazaki, Takashi</creatorcontrib><creatorcontrib>Ohmi, Asako</creatorcontrib><creatorcontrib>Kurumaya, Haruka</creatorcontrib><creatorcontrib>Kato, Kenji</creatorcontrib><creatorcontrib>Abe, Takanori</creatorcontrib><creatorcontrib>Yamamoto, Hiroyuki</creatorcontrib><creatorcontrib>Nakanishi, Noriko</creatorcontrib><creatorcontrib>Okuyama, Ryuichi</creatorcontrib><creatorcontrib>Umemura, Mariko</creatorcontrib><creatorcontrib>Kaise, Toshikazu</creatorcontrib><creatorcontrib>Watanabe, Ryuya</creatorcontrib><creatorcontrib>Okawa, Yoshiko</creatorcontrib><creatorcontrib>Takahashi, Shigeru</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamazaki, Takashi</au><au>Ohmi, Asako</au><au>Kurumaya, Haruka</au><au>Kato, Kenji</au><au>Abe, Takanori</au><au>Yamamoto, Hiroyuki</au><au>Nakanishi, Noriko</au><au>Okuyama, Ryuichi</au><au>Umemura, Mariko</au><au>Kaise, Toshikazu</au><au>Watanabe, Ryuya</au><au>Okawa, Yoshiko</au><au>Takahashi, Shigeru</au><au>Takahashi, Yuji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2010-08-28</date><risdate>2010</risdate><volume>87</volume><issue>9</issue><spage>294</spage><epage>301</epage><pages>294-301</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Activating transcription factor (ATF) 5 is a member of the cAMP response element-binding protein (CREB)/ATF family of transcription factors. We have shown that ATF5 is a stress response transcription factor that responds to amino acid limitation, arsenite exposure, or cadmium exposure. In this study we investigated whether ATF5 is involved in the regulation of CCAAT/enhancer-binding protein (C/EBP) homologous protein (
CHOP) gene expression.
We used a transient transfection system to express ATF5 and analyzed the regulation of
CHOP gene promoter in human hepatoma, HepG2 cells. We also studied the effect of ATF5 knockdown on arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
We showed that ATF5 activates the
CHOP gene promoter in HepG2 cells. Both deletion analysis and point mutations of the promoter revealed that amino acid response element (AARE) 1 is responsible for ATF5-dependent promoter activation. Furthermore, the existence of either AARE1 or activating protein-1 (AP-1) site is sufficient for transcriptional activation of the
CHOP gene promoter by arsenite exposure, although complete induction requires the existence of both elements. We also demonstrated that knockdown of ATF5 reduced arsenite-induced CHOP protein expression and arsenite-induced cell death of HepG2 cells.
These results suggested that the
CHOP gene is a potential target for ATF5, and that ATF5 raises the arsenite-induced
CHOP gene expression level via the AARE1 site in HepG2 cells.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>20654631</pmid><doi>10.1016/j.lfs.2010.07.006</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0024-3205 |
ispartof | Life sciences (1973), 2010-08, Vol.87 (9), p.294-301 |
issn | 0024-3205 1879-0631 |
language | eng |
recordid | cdi_proquest_miscellaneous_817605073 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Activating Transcription Factors - antagonists & inhibitors Activating Transcription Factors - genetics Activating Transcription Factors - physiology Activator protein 1 Amino Acids - pharmacology Apoptosis Apoptosis - drug effects Arsenite Arsenites - pharmacology ATF5 Binding Sites Blotting, Western Cell Survival - drug effects CHOP Cloning, Molecular DDIT3 Dose-Response Relationship, Drug GADD153 Gene Deletion Gene Expression Regulation, Neoplastic - drug effects HeLa Cells Hep G2 Cells Humans Luciferases - genetics Plasmids Point Mutation Promoter Regions, Genetic Response Elements - genetics RNA, Small Interfering - pharmacology Sodium Compounds - pharmacology Transcription Factor AP-1 - genetics Transcription Factor CHOP - genetics Transfection Up-Regulation |
title | Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20the%20human%20CHOP%20gene%20promoter%20by%20the%20stress%20response%20transcription%20factor%20ATF5%20via%20the%20AARE1%20site%20in%20human%20hepatoma%20HepG2%20cells&rft.jtitle=Life%20sciences%20(1973)&rft.au=Yamazaki,%20Takashi&rft.date=2010-08-28&rft.volume=87&rft.issue=9&rft.spage=294&rft.epage=301&rft.pages=294-301&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2010.07.006&rft_dat=%3Cproquest_cross%3E817605073%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749005528&rft_id=info:pmid/20654631&rft_els_id=S0024320510002936&rfr_iscdi=true |